Insider filing · KYMR
Nello Mainolfi
Chief Executive Officer
profile →
Kymera Therapeutics, Inc.
KYMR · Healthcare · 58 filings in 24 months
ticker →
Nello Mainolfi sold $6.0M of Kymera Therapeutics (KYMR)
Executed Jul 7, disclosed Jul 8, the same day.
Value, as filed
$6.0M
50,000 sh × $119.00
Executed
Jul 7
the trade date, as filed
Disclosed
Jul 8
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NMNello Mainolfi (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $9.2M of KYMR (80,000 sh across 5 lots, as filed), executed Jul 1.
The name
KYMRHealthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Nello Mainolfi in KYMR
KYMRSALE
Kymera Therapeutics, Inc.
$9.2M80,000 sh across 5 lots
Exec Jul 1
Filed Jul 2 · 6:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $2.4M
29,064 sh across 2 lots
Exec Apr 29
Filed Apr 29 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $2.7M
29,992 sh across 4 lots
Exec Feb 25
Filed Feb 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $2.3M
30,000 sh across 2 lots
Exec Dec 31 2025
Filed Dec 31 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $8.9M
100,000 sh × $89.17
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $1.8M
30,000 sh across 3 lots
Exec Oct 29 2025
Filed Oct 29 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $1.5M
30,000 sh × $49.00
Exec Sep 16 2025
Filed Sep 16 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $1.5M
30,000 sh × $49.00
Exec Jun 3 2025
Filed Jun 3 2025 · 5:30 PM ET